WVE Wave Life Sciences Ltd.
Healthcare$6.38+0.00%ClosedMarket Cap: $1.23B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.50
P/S
17.10
EV/EBITDA
-3.84
DCF Value
$0.78
FCF Yield
-14.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
93.8%
Operating Margin
-274.2%
Net Margin
-255.7%
ROE
-56.4%
ROA
-31.5%
ROIC
-36.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $38.2M | 100.0% | $-31.3M | $-26.1M | $— | — |
| Q4 null | $17.2M | 86.9% | $-56.5M | $-53.2M | $— | — |
| FY null | $42.7M | 79.3% | $-215.4M | $-204.4M | $— | — |
| Q3 null | $7.6M | 100.0% | $-56.4M | $-53.9M | $— | — |
| Q2 null | $8.7M | 74.8% | $-52.8M | $-50.5M | $— | — |
| Q1 null | $9.2M | 76.4% | $-49.8M | $-46.9M | $— | — |
| Q4 null | $83.7M | 100.0% | $23.0M | $29.3M | $— | — |
| FY null | $108.3M | 100.0% | $-110.4M | $-97.0M | $— | — |
| Q3 null | $-7.7M | 100.0% | $-63.9M | $-61.8M | $— | — |
| Q2 null | $19.7M | 100.0% | $-35.0M | $-32.9M | $— | — |
| Q1 null | $12.5M | 100.0% | $-34.5M | $-31.6M | $— | — |
| Q4 2023 | $29.1M | 92.5% | $-18.7M | $-16.3M | $-0.15 | — |